Vote on Next Markets

Help choose the next clinical trial markets.

Suggestion Inbox

Got an NCT to rank?

Suggest a Market

Vote

1

week

#1NCT05733546

A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder

Drug

Psilocybin

Sponsor

COMPASS Pathways

Condition

Major Depressive Disorder

Status

Active Not Recruiting | PHASE2 | Sep 2025

5 total | 1 suggested

0

week

#2NCT04850118

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

Drug

rAAV2tYF-GRK1-hRPGRco; Control

Sponsor

Beacon Therapeutics

Condition

X-Linked Retinitis Pigmentosa

Status

Active Not Recruiting | PHASE2; PHASE3 | Jun 30, 2026

2 total | 1 suggested

0

week

#3NCT04280705

Adaptive COVID-19 Treatment Trial (ACTT)

Drug

Placebo; Remdesivir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Condition

COVID-19

Status

Completed | PHASE3 | May 21, 2020

1 total | 1 suggested

0

week

#4NCT06389877

A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

Drug

BEAM-302

Sponsor

Beam Therapeutics Inc.

Condition

Alpha 1-Antitrypsin Deficiency

Status

Recruiting | PHASE1; PHASE2 | May 2028

1 total | 1 suggested

0

week

#5NCT06347159

A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)

Drug

EDG-7500

Sponsor

Edgewise Therapeutics, Inc.

Condition

Hypertrophic Cardiomyopathy

Status

Active Not Recruiting | PHASE2 | Jun 2026

1 total | 1 suggested

0

week

#6NCT06109649

A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo

Drug

Afamelanotide and NB-UVB Light; NB-UVB Light

Sponsor

Clinuvel, Inc.

Condition

Vitiligo

Status

Active Not Recruiting | PHASE3 | Dec 2025

0 total | 1 suggested

0

week

#7NCT06344104

A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

Drug

Baxdrostat; Placebo

Sponsor

AstraZeneca

Condition

Uncontrolled Hypertension; Resistant Hypertension

Status

Completed | PHASE3 | Nov 24, 2025

0 total | 1 suggested

0

week

#8NCT07420283

A Study of Brenipatide in Participants With Opioid Use Disorder

Drug

Brenipatide; Placebo; Buprenorphine

Sponsor

Eli Lilly and Company

Condition

Opioid Use Disorder

Status

Recruiting | PHASE2 | Mar 2028

0 total | 1 suggested

0

week

#9NCT07219953

A Study of Brenipatide in Participants With Alcohol Use Disorder

Drug

LY3537031; Placebo

Sponsor

Eli Lilly and Company

Condition

Alcohol Use Disorder

Status

Recruiting | PHASE3 | Apr 2028

0 total | 1 suggested

0

week

#10NCT06634420

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Drug

NTLA-2002; Normal Saline IV Administration

Sponsor

Intellia Therapeutics

Condition

Hereditary Angioedema

Status

Active Not Recruiting | PHASE3 | Feb 10, 2026

0 total | 1 suggested

0

week

#11NCT05933577

A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

Drug

Intismeran autogene; Pembrolizumab; Placebo

Sponsor

Merck Sharp & Dohme LLC

Condition

Melanoma

Status

Active Not Recruiting | PHASE3 | Oct 26, 2029

0 total | 1 suggested